guanidine carboxamide has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestri, LJI; Botta, L; Bugli, F; Casian, A; D'Agostino, I; Deodato, D; Dreassi, E; Marchitiello, R; Mariotti, M; Orofino, F; Rango, E; Sanguinetti, M; Truglio, GI; Vagaggini, C | 1 |
1 other study(ies) available for guanidine carboxamide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents.
Topics: Antifungal Agents; Candida; COVID-19; Cryptococcus neoformans; Microbial Sensitivity Tests | 2022 |